Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 116

1.

Rapidly cleared episodes of oral and anogenital herpes simplex virus shedding in HIV-infected adults.

Mark KE, Wald A, Magaret AS, Selke S, Kuntz S, Huang ML, Corey L.

J Acquir Immune Defic Syndr. 2010 Aug;54(5):482-8. doi: 10.1097/QAI.0b013e3181d91322.

2.

Rapidly cleared episodes of herpes simplex virus reactivation in immunocompetent adults.

Mark KE, Wald A, Magaret AS, Selke S, Olin L, Huang ML, Corey L.

J Infect Dis. 2008 Oct 15;198(8):1141-9. doi: 10.1086/591913.

3.

Longitudinal study on oral shedding of herpes simplex virus 1 and varicella-zoster virus in individuals infected with HIV.

van Velzen M, Ouwendijk WJ, Selke S, Pas SD, van Loenen FB, Osterhaus AD, Wald A, Verjans GM.

J Med Virol. 2013 Sep;85(9):1669-77. doi: 10.1002/jmv.23634. Epub 2013 Jun 18.

4.

Oral herpes simplex virus type 2 reactivation in HIV-positive and -negative men.

Kim HN, Meier A, Huang ML, Kuntz S, Selke S, Celum C, Corey L, Wald A.

J Infect Dis. 2006 Aug 15;194(4):420-7. Epub 2006 Jul 12.

PMID:
16845624
5.

Antiretroviral therapy is not associated with reduced herpes simplex virus shedding in HIV coinfected adults: an observational cohort study.

Tan DH, Raboud JM, Kaul R, Walmsley SL.

BMJ Open. 2014 Jan 24;4(1):e004210. doi: 10.1136/bmjopen-2013-004210.

6.

High Rate of β-Globin DNA Detection Validates Self-Sampling in Herpes Simplex Virus Shedding Studies.

Mujugira A, Huang ML, Selke S, Drolette L, Magaret AS, Wald A.

Sex Transm Dis. 2015 Dec;42(12):705-9. doi: 10.1097/OLQ.0000000000000374.

7.

Persistent genital herpes simplex virus-2 shedding years following the first clinical episode.

Phipps W, Saracino M, Magaret A, Selke S, Remington M, Huang ML, Warren T, Casper C, Corey L, Wald A.

J Infect Dis. 2011 Jan 15;203(2):180-7. doi: 10.1093/infdis/jiq035. Epub 2010 Dec 9.

8.

Herpes simplex virus type 2 (HSV-2) genital shedding in HSV-2-/HIV-1-co-infected women receiving effective combination antiretroviral therapy.

Péré H, Rascanu A, LeGoff J, Matta M, Bois F, Lortholary O, Leroy V, Launay O, Bélec L; ANRS EP24 study group.

Int J STD AIDS. 2016 Mar;27(3):178-85. doi: 10.1177/0956462415577727. Epub 2015 Mar 13.

PMID:
25769886
9.
10.
11.

Genital Herpes Simplex Virus Type 2 Shedding Among Adults With and Without HIV Infection in Uganda.

Phipps W, Nakku-Joloba E, Krantz EM, Selke S, Huang ML, Kambugu F, Orem J, Casper C, Corey L, Wald A.

J Infect Dis. 2016 Feb 1;213(3):439-47. doi: 10.1093/infdis/jiv451. Epub 2015 Oct 20.

12.

Herpes simplex virus shedding and plasma human immunodeficiency virus RNA levels in coinfected women.

Augenbraun M, Corey L, Reichelderfer P, Wright DJ, Burns D, Koelle DM, Robison E, Cohen M; Women's Health Studies 002 Study Group.

Clin Infect Dis. 2001 Sep 15;33(6):885-90. Epub 2001 Aug 10. Erratum in: Clin Infect Dis 2001 Oct 15;33(8):1445.

PMID:
11512094
13.

Herpes simplex virus type 2 shedding in human immunodeficiency virus-negative men who have sex with men: frequency, patterns, and risk factors.

Krone MR, Wald A, Tabet SR, Paradise M, Corey L, Celum CL.

Clin Infect Dis. 2000 Feb;30(2):261-7.

PMID:
10671325
14.

HSV oropharyngeal shedding among HIV-infected children in Tanzania.

Zuckerman R, Manji K, Matee M, Naburi H, Bisimba J, Martinez R, Wieland-Alter W, Kim F, von Reyn CF, Palumbo P.

Int J STD AIDS. 2015 Jun;26(7):456-61. doi: 10.1177/0956462414543122. Epub 2014 Jul 15.

PMID:
25028453
15.

Virologic and immunologic evidence of multifocal genital herpes simplex virus 2 infection.

Johnston C, Zhu J, Jing L, Laing KJ, McClurkan CM, Klock A, Diem K, Jin L, Stanaway J, Tronstein E, Kwok WW, Huang ML, Selke S, Fong Y, Magaret A, Koelle DM, Wald A, Corey L.

J Virol. 2014 May;88(9):4921-31. doi: 10.1128/JVI.03285-13. Epub 2014 Feb 19.

16.

Reactivation of genital herpes simplex virus type 2 infection in asymptomatic seropositive persons.

Wald A, Zeh J, Selke S, Warren T, Ryncarz AJ, Ashley R, Krieger JN, Corey L.

N Engl J Med. 2000 Mar 23;342(12):844-50.

17.

Quantitative and qualitative correlates of cervicovaginal herpes simplex virus type 2 shedding among HIV-infected women in the Women's Interagency HIV Study.

Aumakhan B, Gange SJ, Beyrer C, Gaydos CA, Minkoff H, Merenstein DJ, Cohen MH, Anastos K, Greenblatt R, Nowicki MJ, Quinn TC.

Int J STD AIDS. 2011 May;22(5):273-7. doi: 10.1258/ijsa.2009.009296.

18.

Overlapping reactivations of herpes simplex virus type 2 in the genital and perianal mucosa.

Tata S, Johnston C, Huang ML, Selke S, Magaret A, Corey L, Wald A.

J Infect Dis. 2010 Feb 15;201(4):499-504. doi: 10.1086/650302.

19.

Frequent reactivation of herpes simplex virus among HIV-1-infected patients treated with highly active antiretroviral therapy.

Posavad CM, Wald A, Kuntz S, Huang ML, Selke S, Krantz E, Corey L.

J Infect Dis. 2004 Aug 15;190(4):693-6. Epub 2004 Jul 13.

PMID:
15272395
20.

Oral mucosal reactivation rates of herpesviruses among HIV-1 seropositive persons.

Griffin E, Krantz E, Selke S, Huang ML, Wald A.

J Med Virol. 2008 Jul;80(7):1153-9. doi: 10.1002/jmv.21214.

PMID:
18461621

Supplemental Content

Support Center